newsfilter
← Latest News
PR Newswire·

SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

BOSTON, Oct. 8, 2026 /CNW/ -- SOPHiA GENETICS (NASDAQ:SOPH) and Myriad Genetics, Inc., (NASDAQ:MYGN) today announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to